Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 119

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 119
---
 Total Shares of Common Stock and Preferred Stock Outstanding Upon Consummation of the Business Combination.” Material Financing Transactions in connection with the Business Combination Since the IPO, the material financing transactions listed in the table below have occurred or will occur in connection with the consummation of the Business Combination, as described in further detail following the table.

| Date 
 2023 |     | Description                                       
 Sponsor Convertible Promissory Note (1)           |     | Maximum   
 Principal 
 Amount    | 2,000,000 |     | Outstanding  
 Amount as of 
 March 31,    
 2025         | 1,408,200 |
|:-----|:----|:--------------------------------------------------|:----|:----------|----------:|:----|:-------------|----------:|
| 2023 |     | FutureTech Convertible Promissory Note (2)        |     | $         |   825,000 |     | $            |   825,000 |
| 2023 |     | Second FutureTech Convertible Promissory Note (3) |     | $         |   450,000 |     | $            |   450,000 |
| 2024 |     | Sponsor Extension Convertible Promissory Note (4) |     | $         |   180,000 |     | $            |   115,037 |
| 2024 |     | Scilex Convertible Promissory Note (5)            |     | $         |   180,000 |     | $            |   120,482 |

| (1) | On April 11, 2023, Denali issued the Sponsor Convertible Promissory Note for working capital purposes in the total principal amount of up to $825,000 to the Sponsor (the “Initial Principal Amount”). The Sponsor Convertible Promissory Note was issued with an initial principal balance of $412,500, with the remaining $412,500 drawable at Denali’s request prior to the maturity of the Sponsor Convertible Promissory Note. On December 29, 2023, Denali and the Sponsor agreed that, in addition to the Initial Principal Amount, Denali may request an additional aggregate amount of up to $157,500, which may be drawn down in one or more tranches at any time prior to the maturity date of the Sponsor Convertible Promissory Note, raising the total limit up to $1,000,000. On April